942 resultados para Clinical practice
Resumo:
PURPOSE:
To assess the accuracy of Travatan Dosing Aid recordings.
DESIGN:
Prospective evaluation of drop-recording accuracy.
METHODS:
Physicians and patients used the Dosing Aid, and logs of usage were compared to the data obtained from the Dosing Aid.
RESULTS:
Five physicians and 20 patients participated. Devices used by physicians recorded all drops dispensed. Extra readings were recorded when physicians carried the devices during the day. For patients, 93% of all drops were recorded, with 18 of 20 subjects having over 85% of the drops recorded. Seventy percent of patients would continue using the device.
CONCLUSIONS:
The Dosing Aid accurately recorded most eyedrops administered by patients and physicians. Given recent documentation of widespread under-compliance with medical therapy, the Dosing Aid could be a useful addition to clinical practice and research.
Resumo:
Importance Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS).
Objectives To evaluate intensive care unit (ICU) incidence and outcome of ARDS and to assess clinician recognition, ventilation management, and use of adjuncts—for example prone positioning—in routine clinical practice for patients fulfilling the ARDS Berlin Definition.
Design, Setting, and Participants The Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an international, multicenter, prospective cohort study of patients undergoing invasive or noninvasive ventilation, conducted during 4 consecutive weeks in the winter of 2014 in a convenience sample of 459 ICUs from 50 countries across 5 continents.
Exposures Acute respiratory distress syndrome.
Main Outcomes and Measures The primary outcome was ICU incidence of ARDS. Secondary outcomes included assessment of clinician recognition of ARDS, the application of ventilatory management, the use of adjunctive interventions in routine clinical practice, and clinical outcomes from ARDS.
Results Of 29 144 patients admitted to participating ICUs, 3022 (10.4%) fulfilled ARDS criteria. Of these, 2377 patients developed ARDS in the first 48 hours and whose respiratory failure was managed with invasive mechanical ventilation. The period prevalence of mild ARDS was 30.0% (95% CI, 28.2%-31.9%); of moderate ARDS, 46.6% (95% CI, 44.5%-48.6%); and of severe ARDS, 23.4% (95% CI, 21.7%-25.2%). ARDS represented 0.42 cases per ICU bed over 4 weeks and represented 10.4% (95% CI, 10.0%-10.7%) of ICU admissions and 23.4% of patients requiring mechanical ventilation. Clinical recognition of ARDS ranged from 51.3% (95% CI, 47.5%-55.0%) in mild to 78.5% (95% CI, 74.8%-81.8%) in severe ARDS. Less than two-thirds of patients with ARDS received a tidal volume 8 of mL/kg or less of predicted body weight. Plateau pressure was measured in 40.1% (95% CI, 38.2-42.1), whereas 82.6% (95% CI, 81.0%-84.1%) received a positive end-expository pressure (PEEP) of less than 12 cm H2O. Prone positioning was used in 16.3% (95% CI, 13.7%-19.2%) of patients with severe ARDS. Clinician recognition of ARDS was associated with higher PEEP, greater use of neuromuscular blockade, and prone positioning. Hospital mortality was 34.9% (95% CI, 31.4%-38.5%) for those with mild, 40.3% (95% CI, 37.4%-43.3%) for those with moderate, and 46.1% (95% CI, 41.9%-50.4%) for those with severe ARDS.
Conclusions and Relevance Among ICUs in 50 countries, the period prevalence of ARDS was 10.4% of ICU admissions. This syndrome appeared to be underrecognized and undertreated and associated with a high mortality rate. These findings indicate the potential for improvement in the management of patients with ARDS.
Resumo:
OBJECTIVES: The Shape of Training report recommended that full registration is aligned with medical school graduation. As part of a General Medical Council-funded study about the preparedness for practice of UK medical graduates, we explored UK stakeholders' views about this proposal using qualitative interviews (30 group and 87 individual interviews) and Framework Analysis.
SETTING: Four UK study sites, one in each country.Save
PARTICIPANTS: 185 individuals from eight stakeholder groups: (1) foundation year 1 (F1) doctors (n=34); (2) fully registered trainee doctors (n=33); (3) clinical educators (n=32); (4) undergraduate/postgraduate Deans, and Foundation Programme Directors (n=30); (5) other healthcare professionals (n=13); (6) employers (n=7); (7) policy and government (n=11); (8) patient and public representatives (n=25).
RESULTS: We identified four main themes: (1) The F1 year as a safety net: patients were protected by close trainee supervision and 'sign off' to prevent errors; trainees were provided with a safe environment for learning on the job; (2) Implications for undergraduate medical education: if the proposal was accepted, a 'radical review' of undergraduate curricula would be needed; undergraduate education might need to be longer; (3) Implications for F1 work practice: steps to protect healthcare team integration and ensure that F1 doctors stay within competency limits would be required; (4) Financial, structural and political implications: there would be cost implications for trainees; clarification of responsibilities between undergraduate and postgraduate medical education would be needed. Typically, each theme comprised arguments for and against the proposal.
CONCLUSIONS: A policy change to align the timing of full registration with graduation would require considerable planning and preliminary work. These findings will inform policymakers' decision-making. Regardless of the decision, medical students should take on greater responsibility for patient care as undergraduates, assessment methods in clinical practice and professionalism domains need development, and good practice in postgraduate supervision and support must be shared.
Resumo:
Introduction The majority of stage III patients with non-small cell lung cancer (NSCLC) are unsuitable for concurrent chemoradiotherapy, the non-surgical gold standard of care. As the alternative treatment options of sequential chemoradiotherapy and radiotherapy alone are associated with high local failure rates, various intensification strategies have been employed. There is evidence to suggest that altered fractionation using hyperfractionation, acceleration, dose escalation, and individualisation may be of benefit. The MAASTRO group have pioneered the concept of ‘isotoxic’ radiotherapy allowing for individualised dose escalation using hyperfractionated accelerated radiotherapy based on predefined normal tissue constraints. This study aims to evaluate whether delivering isotoxic radiotherapy using intensity modulated radiotherapy (IMRT) is achievable.
Methods and analysis Isotoxic IMRT is a multicentre feasibility study. From June 2014, a total of 35 patients from 7 UK centres, with a proven histological or cytological diagnosis of inoperable NSCLC, unsuitable for concurrent chemoradiotherapy will be recruited. A minimum of 2 cycles of induction chemotherapy is mandated before starting isotoxic radiotherapy. The dose of radiation will be increased until one or more of the organs at risk tolerance or the maximum dose of 79.2 Gy is reached. The primary end point is feasibility, with accrual rates, local control and overall survival our secondary end points. Patients will be followed up for 5 years.
Ethics and dissemination The study has received ethical approval (REC reference: 13/NW/0480) from the National Research Ethics Service (NRES) Committee North West—Greater Manchester South. The trial is conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP). The trial results will be published in a peer-reviewed journal and presented internationally.
Trial registration number NCT01836692; Pre-results.
Resumo:
Modern approaches to biomedical research and diagnostics targeted towards precision medicine are generating ‘big data’ across a range of high-throughput experimental and analytical platforms. Integrative analysis of this rich clinical, pathological, molecular and imaging data represents one of the greatest bottlenecks in biomarker discovery research in cancer and other diseases. Following on from the publication of our successful framework for multimodal data amalgamation and integrative analysis, Pathology Integromics in Cancer (PICan), this article will explore the essential elements of assembling an integromics framework from a more detailed perspective. PICan, built around a relational database storing curated multimodal data, is the research tool sitting at the heart of our interdisciplinary efforts to streamline biomarker discovery and validation. While recognizing that every institution has a unique set of priorities and challenges, we will use our experiences with PICan as a case study and starting point, rationalizing the design choices we made within the context of our local infrastructure and specific needs, but also highlighting alternative approaches that may better suit other programmes of research and discovery. Along the way, we stress that integromics is not just a set of tools, but rather a cohesive paradigm for how modern bioinformatics can be enhanced. Successful implementation of an integromics framework is a collaborative team effort that is built with an eye to the future and greatly accelerates the processes of biomarker discovery, validation and translation into clinical practice.
Resumo:
BACKGROUND: Cerebral palsy is a permanent disorder of posture and movement caused by disturbances in the developing brain. It affects approximately 1 in every 500 children in developed countries and is the most common form of childhood physical disability. People with cerebral palsy may also have problems with speech, vision and hearing, intellectual difficulties and epilepsy. Health and therapy services are frequently required throughout life, and this care should be effective and evidence informed; however, accessing and adopting new research findings into day-to-day clinical practice is often delayed.
METHODS/DESIGN: This 3-year study employs a before and after design to evaluate if a multi-strategy intervention can improve research implementation among allied health professionals (AHPs) who work with children and young people with cerebral palsy and to establish if children's health outcomes can be improved by routine clinical assessment. The intervention comprises (1) knowledge brokering with AHPs, (2) access to an online research evidence library, (3) provision of negotiated evidence-based training and education, and (4) routine use of evidence-based measures with children and young people aged 3-18 years with cerebral palsy. The study is being implemented in four organisations, with a fifth organisation acting as a comparison site, across four Australian states. Effectiveness will be assessed using questionnaires completed by AHPs at baseline, 6, 12 and 24 months, and by monitoring the extent of use of evidence-based measures. Children's health outcomes will be evaluated by longitudinal analyses.
DISCUSSION: Government, policy makers and service providers all seek evidence-based information to support decision-making about how to distribute scarce resources, and families are seeking information to support intervention choices. This study will provide knowledge about what constitutes an efficient, evidence-informed service and which allied health interventions are implemented for children with cerebral palsy.
TRIAL REGISTRATION: Trial is not a controlled healthcare intervention and is not registered.
Resumo:
AIM: To incorporate basic aspects of acute care into the undergraduate nursing programme by providing an opportunity for the development of knowledge and skills in the early recognition and assessment of deteriorating patients on general hospital wards.
BACKGROUND: Acute care initiatives implemented in the hospital setting to improve the identification and management of 'at risk' patients have focused on the provision of education for trained or qualified staff. However, to ensure student nurses are 'fit to practice' at the point of registration, it has been recommended that acute care theory and skills are incorporated into the undergraduate nursing curriculum.
PRACTICE DEVELOPMENT INITIATIVE: An 'Integrated Nursing Care' module was incorporated into year 3 of the undergraduate nursing programme to introduce students to acute care theory and practice. Module content focuses on the early detection and management of acute deterioration in patients with respiratory, cardiac, neurological or renal insufficiencies. We used a competency-based framework to ensure the application of theory to practice through the use of group seminars. High-fidelity patient-simulated clinical scenarios were a key feature. The United Kingdom Resuscitation Council Intermediate Life Support course is also an important component of the module.
CONCLUSIONS: Incorporating the Integrated Nursing Care module into the undergraduate nursing curriculum provides pre-registration students the opportunity to develop their knowledge and skills in acute care.
RELEVANCE TO CLINICAL PRACTICE: The provision of undergraduate education in care of the acutely ill patient in hospital is essential to improve nurses' competence and confidence in assessing and managing deteriorating patients in general wards at the point of registration.
Resumo:
PURPOSE: Concerns were raised about the safety of antiplatelet thienopyridine derivatives after a randomized control trial reported increased risks of cancer and cancer deaths in prasugrel users. We investigate whether clopidogrel, a widely used thienopyridine derivative, was associated with increased risk of cancer-specific or all-cause mortality in cancer patients.
METHODS: Colorectal, breast and prostate cancer patients, newly diagnosed from 1998 to 2009, were identified from the National Cancer Data Repository. Cohorts were linked to the UK Clinical Practice Research Datalink, providing prescription records, and to the Office of National Statistics mortality data (up to 2012). Unadjusted and adjusted hazard ratios (HRs) for cancer-specific and all-cause mortality in post-diagnostic clopidogrel users were calculated using time-dependent Cox regression models.
RESULTS: The analysis included 10 359 colorectal, 17 889 breast and 13 155 prostate cancer patients. There was no evidence of an increase in cancer-specific mortality in clopidogrel users with colorectal (HR = 0.98 95% confidence interval (CI) 0.77, 1.24) or prostate cancer (HR = 1.03 95%CI 0.82, 1.28). There was limited evidence of an increase in breast cancer patients (HR = 1.22 95%CI 0.90, 1.65); however, this was attenuated when removing prescriptions in the year prior to death.
CONCLUSIONS: This novel study of large population-based cohorts of colorectal, breast and prostate cancer patients found no evidence of an increased risk of cancer-specific mortality among colorectal, breast and prostate cancer patients using clopidogrel.
Resumo:
BACKGROUND: Preclinical studies have shown that statins, particularly simvastatin, can prevent growth in breast cancer cell lines and animal models. We investigated whether statins used after breast cancer diagnosis reduced the risk of breast cancer-specific, or all-cause, mortality in a large cohort of breast cancer patients.
METHODS: A cohort of 17,880 breast cancer patients, newly diagnosed between 1998 and 2009, was identified from English cancer registries (from the National Cancer Data Repository). This cohort was linked to the UK Clinical Practice Research Datalink, providing prescription records, and to the Office of National Statistics mortality data (up to 2013), identifying 3694 deaths, including 1469 deaths attributable to breast cancer. Unadjusted and adjusted hazard ratios (HRs) for breast cancer-specific, and all-cause, mortality in statin users after breast cancer diagnosis were calculated using time-dependent Cox regression models. Sensitivity analyses were conducted using multiple imputation methods, propensity score methods and a case-control approach.
RESULTS: There was some evidence that statin use after a diagnosis of breast cancer had reduced mortality due to breast cancer and all causes (fully adjusted HR = 0.84 [95% confidence interval = 0.68-1.04] and 0.84 [0.72-0.97], respectively). These associations were more marked for simvastatin 0.79 (0.63-1.00) and 0.81 (0.70-0.95), respectively.
CONCLUSIONS: In this large population-based breast cancer cohort, there was some evidence of reduced mortality in statin users after breast cancer diagnosis. However, these associations were weak in magnitude and were attenuated in some sensitivity analyses.
Resumo:
BACKGROUND & AIMS: Individuals who began taking low-dose aspirin before they were diagnosed with colorectal cancer were reported to have longer survival times than patients who did not take this drug. We investigated survival times of patients who begin taking low-dose aspirin after a diagnosis of colorectal cancer in a large population-based cohort study.
METHODS: We performed a nested case-control analysis using a cohort of 4794 patients diagnosed with colorectal cancer from 1998 through 2007, identified from the UK Clinical Practice Research Datalink and confirmed by cancer registries. There were 1559 colorectal cancer-specific deaths, recorded by the Office of National Statistics; these were each matched with up to 5 risk-set controls. Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI), based on practitioner-recorded aspirin usage.
RESULTS: Overall, low-dose aspirin use after a diagnosis of colorectal cancer was not associated with colorectal cancer-specific mortality (adjusted OR = 1.06; 95% CI: 0.92-1.24) or all-cause mortality (adjusted OR = 1.06; 95% CI: 0.94-1.19). A dose-response association was not apparent; for example, low-dose aspirin use for more than 1 year after diagnosis was not associated with colorectal cancer-specific mortality (adjusted OR = 0.98; 95% CI: 0.82-1.19). There was also no association between low-dose aspirin usage and colon cancer-specific mortality (adjusted OR = 1.02; 95% CI: 0.83-1.25) or rectal cancer-specific mortality (adjusted OR = 1.10; 95% CI: 0.88-1.38).
CONCLUSIONS: In a large population-based cohort, low-dose aspirin usage after diagnosis of colorectal cancer did not increase survival time.
Resumo:
BACKGROUND:
Digoxin has been shown to affect a number of pathways that are of relevance to cancer, and its use has been associated with increased risks of breast and uterus cancer and, more recently, a 40% increase in colorectal cancer risk. These findings raise questions about the safety of digoxin use in colorectal cancer patients, and, therefore, we investigated whether digoxin use after colorectal cancer diagnosis increased the risk of colorectal cancer-specific mortality.
METHODS:
A cohort of 10,357 colorectal cancer patients newly diagnosed from 1998 to 2009 was identified from English cancer registries and linked to the UK Clinical Practice Research Datalink (to provide digoxin and other prescription records) and to the Office of National Statistics mortality data (to identify 2,724 colorectal cancer-specific deaths). Using time-dependent Cox regression models, unadjusted and adjusted HRs and 95% confidence intervals (CI) were calculated for the association between postdiagnostic exposure to digoxin and colorectal cancer-specific mortality.
RESULTS:
Overall, 682 (6%) colorectal cancer patients used digoxin after diagnosis. Digoxin use was associated with a small increase in colorectal cancer-specific mortality before adjustment (HR, 1.25; 95% CI, 1.07-1.46), but after adjustment for confounders, the association was attenuated (adjusted HR, 1.10; 95% CI, 0.91-1.34) and there was no evidence of a dose response.
CONCLUSIONS:
In this large population-based colorectal cancer cohort, there was little evidence of an increase in colorectal cancer-specific mortality with digoxin use after diagnosis.
IMPACT:
These results provide some reassurance that digoxin use is safe in colorectal cancer patients.
Resumo:
The practical knowledge has characteristics of a process with peculiar idiosyncrasies that require disruption with preconceived ideas, dialogue, negotiation and joint action. The knowledge underlying remains unclear despite of being what informs decision making. It is academia’s responsibility to unveil and nominate knowledge and that is the reason why we conducted two studies with clinical nurses. The aim is to understand the social representation that nurses make of their knowledge about nursing and analyze their clinical practices. In one of the studies, based on the theoretical-methodological referential of social representations, we used the technique of free association of words with the stimulus “knowledge in nursing”. In another study, developed within a naturalistic context and under the “Grounded Theory” referential, we used non-participative observation and explanatory interviews. From the first study we identified the structure of social representations of knowledge in nursing, from which emerged the central core constituted by four elements (Investigation, Wisdom, help Relation, Competence) and a second periphery with one element (Reflection). With the second study we identified that decisions are made within a dynamic, systematic and continuous process of diagnostic evaluation and clinical intervention using the various types of knowledge (e.g. clinic, experiential, scientific, personal). We concluded that the various types of knowledge in nursing, represented by the expressions mentioned above, are systematically and creatively mobilized within the dynamic process of diagnostic evaluation and clinical intervention. It is therefore important to unveil and nominate the different knowledge implicit in the clinical practice and Academia should be responsible for that task.
Resumo:
UNVEILING PROFESSIONAL KNOWLEDGES: A SCOPE OF HIGHER EDUCATION The practical knowledge has characteristics of a process with peculiar idiosyncrasies that require disruption with preconceived ideas, dialogue, negotiation and joint action. The knowledge underlying remains unclear despite of being what informs decision making. It is academia’s responsibility to unveil and nominate knowledge and that is the reason why we conducted two studies with clinical nurses. The aim is to understand the social representation that nurses make of their knowledge about nursing and analyze their clinical practices. In one of the studies, based on the theoretical-methodological referential of social representations, we used the technique of free association of words with the stimulus “knowledge in nursing”. In another study, developed within a naturalistic context and under the “Grounded Theory” referential, we used non-participative observation and explanatory interviews. From the first study we identified the structure of social representations of knowledge in nursing, from which emerged the central core constituted by four elements (Investigation, Wisdom, help Relation, Competence) and a second periphery with one element (Reflection). With the second study we identified that decisions are made within a dynamic, systematic and continuous process of diagnostic evaluation and clinical intervention using the various types of knowledge (e.g. clinic, experiential, scientific, personal). We concluded that the various types of knowledge in nursing, represented by the expressions mentioned above, are systematically and creatively mobilized within the dynamic process of diagnostic evaluation and clinical intervention. It is therefore important to unveil and nominate the different knowledge implicit in the clinical practice and Academia should be responsible for that task.
Resumo:
Considerando a família como foco de atenção em enfermagem de saúde mental e psiquiatria, foi realizada a análise da prática clínica de enfermagem no âmbito da prestação de cuidados em visita domiciliária, através dos registos de enfermagem existentes nesse contexto. Partindo dos conceitos de enfermagem de saúde mental e psiquiatria, família, modelos teóricos de avaliação e intervenção familiar e visita domiciliária; procurou-se compreender que modelos de abordagem familiar emergem dos registos de enfermagem das visitas domiciliárias, assim como identificar intervenções dirigidas a utentes e familiares numa perspectiva sistémica. Embora sem identificação completa com modelos teóricos existentes, concluímos que existe, sem dúvida, atenção dada aos familiares, sendo realizada frequentemente avaliação de relacionamentos, padrões de interacção, apoios e recursos, necessitando de melhorias que permitam que seja realizada de uma forma sistematizada, criteriosa, fundamentada e claramente documentada; ABSTRACT: Considering family care central, in psychiatric mental health nursing, an analyses of nursing clinical practice in home care context, was accomplished; using the nursing notes existents in that context. Based on concepts of psychiatric mental health nursing, family, conceptual models of family assessment and intervention and home care; we tried to understand what kind of family approach emerges from the nursing notes, as well as identify what interventions are directed to patients and families in a systemic perspective. Although without clear identification of the conceptual models existents, we realise that attention giving to families, exists, without doubted, with frequent relationships assessments, interaction patterns, supports and resources, however with the need to improve in a more grounded, systematic and discerning way and clearly documented.
Resumo:
A prestação de cuidados de saúde coloca os novos enfermeiros face a situações complexas que exigem a mobilização de um conjunto de saberes próprios a fim de poderem responder de modo eficaz à diversidade, imprevisibilidade e singularidade de cada situação da prática clínica. Os ensinos clínicos são momentos determinantes na formação dos enfermeiros, pois são simultaneamente momentos de transformação de saberes, de aquisição da profissionalidade e de desenvolvimento de perfis de competências. Estas três dimensões fomentam a consciencialização do estudante para assumir novos papéis, através do confronto com situações concretas de saúde e de doença. É também neste confronto com as situações reais que surgem conflitos que envolvem valores, atitudes e emoções. Trata-se de momentos difíceis, geradores de stress, mas de importância fundamental para o desenvolvimento do processo de pensamento e construção do juízo ético. Analisar o processo global de construção do pensamento ético como sistema de desenvolvimento humano nos estudantes de enfermagem, contribuindo para a construção de saberes dirigidos para as estratégias que poderão influenciar a aprendizagem da ética no contexto da formação inicial dos enfermeiros, foi a nossa principal preocupação. Realizamos um estudo etnográfico, tipo estudo de caso, inserido numa metodologia multimétodo (quantitativa e qualitativa), na Escola Superior de Enfermagem do Porto. A investigação decorreu em três tempos distintos. Num primeiro momento, foi identificada a orientação moral dos estudantes através da aplicação de um questionário (EPQ); num segundo tempo, foi efectuada uma observação participante no sentido de identificar as formas de pensamento dos estudantes e os factores que as influenciaram ou dificultaram; num terceiro momento, foram realizadas entrevistas de forma a clarificar e aprofundar as informações recolhidas. No tratamento da informação emergiram seis dimensões de análise (contexto da prática, trajectórias da aprendizagem, influência dos modelos da prática, dinâmicas de tutoria - supervisão - e desafios de ordem ética) que nos permitiram compreender a natureza das situações éticas e os padrões de resposta dos estudantes face a essas situações, a influência do ensino da ética e também os factores influenciadores das formas de pensamento ético. A análise dos resultados revelou que, ao longo do curso de enfermagem, os estudantes desenvolvem o seu pensamento ético numa interacção recíproca de si próprios como pessoas activas (estudante) e o ambiente (contexto), onde se encontram em permanente crescimento (desenvolvimento humano), sendo que o ambiente se encontra também em constante transformação. Isto ocorre num movimento crescente, que se inicia com o “aprender a pensar” através do conhecimento acumulado (saber teórico) que lhes permite desenvolver uma actuação através do “aprender fazendo” (saber prático) de modo a atingirem com sucesso a transição para o mundo do trabalho. Tal como qualquer outro processo, o desenvolvimento do pensamento acontece em paralelo com a construção da aprendizagem, segundo etapas ou fases, que caracterizamos como: maturação, consolidação e autonomização. Ao longo do trabalho foram identificados aspectos fundamentais que carecem de reflexão e mudança nos contextos da formação inicial dos enfermeiros, cuja influência é preponderante no desenvolvimento do pensamento ético, dos quais salientamos: a nível da formação (contextos de ensino, processos supervisivos e formação de supervisores) e a nível do currículo (Plano de Estudos).
